146 related articles for article (PubMed ID: 10150187)
1. Rationale for the use of antiplatelet drugs in patients with peripheral vascular disease.
Violi F; Balsano F
Clin Trials Metaanal; 1994 Apr; 29(1):81-7. PubMed ID: 10150187
[TBL] [Abstract][Full Text] [Related]
2. [The future prospects of antithrombotic therapy in peripheral vasculopathy].
Violi F; Loffredo L; Annessi M
Ann Ital Med Int; 1999; 14(3):185-91. PubMed ID: 10566184
[TBL] [Abstract][Full Text] [Related]
3. [Role of antiaggregants in the treatment of arterial diseases of the lower limbs].
Boissel JP
Arch Mal Coeur Vaiss; 1991 Nov; 84(11 Suppl):1721-4. PubMed ID: 1837446
[TBL] [Abstract][Full Text] [Related]
4. Optimal medical management of peripheral arterial disease.
Rice TW; Lumsden AB
Vasc Endovascular Surg; 2006; 40(4):312-27. PubMed ID: 16959725
[TBL] [Abstract][Full Text] [Related]
5. Comparison of efficacy of antiplatelet treatments for patients with claudication. A meta-analysis.
Basili S; Raparelli V; Vestri A; Di Tanna GL; Violi F
Thromb Haemost; 2010 Apr; 103(4):766-73. PubMed ID: 20174763
[TBL] [Abstract][Full Text] [Related]
6. Role of antiplatelet therapy in cardiovascular disease III: Peripheral arterial disease.
Cavendish JJ; Safani M
Curr Med Res Opin; 2004 Nov; 20(11):1851-5. PubMed ID: 15537486
[TBL] [Abstract][Full Text] [Related]
7. [Antiplatelet and anticoagulant treatment after percutaneous transluminal angioplasty for peripheral arteriosclerosis. Survey of a Cochrane review].
Lorenzen ND; Eldrup N; Laustsen J
Ugeskr Laeger; 2007 Sep; 169(39):3279-82. PubMed ID: 17953885
[No Abstract] [Full Text] [Related]
8. The effects of oral anticoagulants in patients with peripheral arterial disease: rationale, design, and baseline characteristics of the Warfarin and Antiplatelet Vascular Evaluation (WAVE) trial, including a meta-analysis of trials.
WAVE Investigators
Am Heart J; 2006 Jan; 151(1):1-9. PubMed ID: 16368284
[TBL] [Abstract][Full Text] [Related]
9. Combination antiplatelet therapy in patients with peripheral arterial disease: is the best therapy aspirin, clopidogrel, or both?
Mohler ER
Catheter Cardiovasc Interv; 2009 Jul; 74 Suppl 1():S1-6. PubMed ID: 19213065
[TBL] [Abstract][Full Text] [Related]
10. Oral buflomedil in the prevention of cardiovascular events in patients with peripheral arterial obstructive disease: a randomized, placebo-controlled, 4-year study.
; Leizorovicz A; Becker F
Circulation; 2008 Feb; 117(6):816-22. PubMed ID: 18212283
[TBL] [Abstract][Full Text] [Related]
11. Statins and peripheral arterial disease: effects on claudication, disease progression, and prevention of cardiovascular events.
Coppola G; Novo S
Arch Med Res; 2007 Jul; 38(5):479-88. PubMed ID: 17560452
[TBL] [Abstract][Full Text] [Related]
12. Clopidogrel added to aspirin versus aspirin alone in secondary prevention and high-risk primary prevention: rationale and design of the Clopidogrel for High Atherothrombotic Risk and Ischemic Stabilization, Management, and Avoidance (CHARISMA) trial.
Bhatt DL; Topol EJ;
Am Heart J; 2004 Aug; 148(2):263-8. PubMed ID: 15308995
[TBL] [Abstract][Full Text] [Related]
13. Pharmacotherapy before and after revascularization: anticoagulation, antiplatelet agents, and statins.
Dagher NN; Modrall JG
Semin Vasc Surg; 2007 Mar; 20(1):10-4. PubMed ID: 17386359
[TBL] [Abstract][Full Text] [Related]
14. Use of antiplatelet agents and anticoagulants for cardiovascular disease: current standards and best practices.
Faxon DP
Rev Cardiovasc Med; 2005; 6 Suppl 4():S3-14. PubMed ID: 17710074
[TBL] [Abstract][Full Text] [Related]
15. Antiplatelet therapy for the prevention of recurrent stroke and other serious vascular events: a review of the clinical trial data and guidelines.
Hankey GJ
Curr Med Res Opin; 2007 Jun; 23(6):1453-62. PubMed ID: 17559741
[TBL] [Abstract][Full Text] [Related]
16. Update on aspirin in the treatment and prevention of cardiovascular disease.
Hennekens CH
Am J Manag Care; 2002 Dec; 8(22 Suppl):S691-700. PubMed ID: 12512736
[TBL] [Abstract][Full Text] [Related]
17. Does the preventive effect of different drugs depend on location of the atherosclerotic process?
Poredos P; Jezovnik MK
Int Angiol; 2008 Aug; 27(4):274-80. PubMed ID: 18677288
[TBL] [Abstract][Full Text] [Related]
18. Consensus on anti-platelet therapy in peripheral arterial disease: saving lives and limbs.
Donnelly R; Collinson DJ
Platelets; 2003; 14(7-8):403-6. PubMed ID: 14713508
[No Abstract] [Full Text] [Related]
19. Pharmacologic risk factor treatment of peripheral arterial disease is lacking and requires vascular surgeon participation.
Bianchi C; Montalvo V; Ou HW; Bishop V; Abou-Zamzam AM
Ann Vasc Surg; 2007 Mar; 21(2):163-6. PubMed ID: 17349357
[TBL] [Abstract][Full Text] [Related]
20. Pharmacologic therapy for peripheral arterial disease and claudication.
Hiatt WR
J Vasc Surg; 2002 Dec; 36(6):1283-91. PubMed ID: 12469066
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
